AXSM Stock Topples As Teva Plans Its Depression Drug Knockoff

Teva Pharmaceutical (TEVA) said Monday it plans a competing knockoff of Axsome Therapeutics‘ (AXSM) new depression treatment, leading AXSM stock to tumble. X Axsome only just gained Food and Dru...

Axsome’s stock falls after disclosing Teva’s plans to market generic Auvelity

Shares of Axsome Therapeutics Inc. AXSM, +0.49% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. TEVA, +0.34% i...

Axsome Stock Is Flying as Fast-Acting Depression Drug Wins FDA Approval

Text size The decision on the drug came a bit less than a year after the FDA’s self-imposed deadline on making a call had passed. Dreamstime The Food and Drug Administration issued a long-awaite...

Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

Text size Axsome is reviewing the proposed labeling from the FDA. Dreamstime Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attemp...

AXSM Stock Reverses Its Good Fortune On A Roadblock For Its Migraine Drug

Axsome Therapeutics (AXSM) says it expects the Food and Drug Administration to reject its migraine treatment, leading AXSM stock to crumble on Monday. X In a filing with the Securities and Exchange Co...

AXSM Stock Rockets As Its First FDA Approval Looks Imminent

Axsome Therapeutics (AXSM) said Tuesday it agreed to the Food and Drug Administration’s requirements for approving its depression drug, and AXSM stock rocketed. X With FDA negotiations behind it...